1. Shortcomings in the US pharmaceutical supply chain: potential risks associated with international manufacturing and trade-related tariffs.;Oehler;JAMA
2. US Food and Drug Administration. Coronavirus (COVID-19) supply chain update. February 27, 2020. Accessed March 24, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update
3. Medicine Use and Spending in the United States: A Review of 2018 and Outlook to 2023. Published May 2019. Accessed March 23, 2020. https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023
4. Ferguson? NM, Laydon? D, Nedjati-Gilani? G, ; Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Published March 16, 2020. Accessed March 23, 2020. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf
5. Erman? M. J&J’s Tylenol production at maximum capacity as coronavirus boosts demand. Reuters. March 19, 2020. Accessed March 23, 2020. https://www.reuters.com/article/us-health-coronavirus-johnson-johnson/jjs-tylenol-production-at-maximum-capacity-as-coronavirus-boosts-demand-idUSKBN2162FU